Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

2026 Myelin Gordon Research Conference and Seminar

Award Number: R13NS149650
ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 05/11/2026
PERIOD OF PERFORMANCE END DATE: 04/30/2027

Group Awards By:

View Award Description

2026 Myelin Gordon Research Conference and Seminar - Project Summary/Abstract Myelinating glial cells play diverse and essential roles in nervous system development and function throughout life. Disruptions to these cells are increasingly recognized in a wide range of neurological conditions, from neurodevelopmental disorders to age-related neurodegenerative diseases. Our understanding of their functions and interactions is rapidly advancing. For instance, myelinating glia are critical in closing periods of heightened plasticity during neural circuit formation. Oligodendrocyte lineage cells also respond dynamically to neuronal activity, enhancing myelination in ways that can be both beneficial and harmful—supporting neural adaptation but also contributing to addiction and facilitating the integration of cancer cells into neural circuits. Promising clinical trials are underway, driven by extensive research into both central and peripheral myelin disorders. Moreover, these glial cells are now implicated in more diseases than previously appreciated, and ongoing studies are likely to yield novel therapeutic strategies. Cutting-edge research is yielding conceptual, mechanistic, and translational insights, and the objective of the 2026 Gordon Research Seminar (GRS: May 23-24, 2026) and Conference (GRC: May 24-29, 2026) on myelin will provide an interactive platform for the community to share their latest findings and develop essential collaborations to advance the field. Taken together the 2026 Myelin GRC, “Myelinating glia and their interactions in health and disease” and the Myelin GRS, “The Leading Edge: Myelinating Glia at the Forefront of Health and Disease” will accomplish this objective by; 1) convening an international meeting of academic, clinical, and industry scientists studying myelinating glial cells in health and disease; 2) discussing exciting new developments by selecting presenters to share unpublished data, with many presentation slots reserved for talks selected from abstracts; 3) promoting collaborative interactions to accelerate conceptual discovery and therapeutic advances; 4) offering trainees as well as established investigators an opportunity to present their work, engage with other scientists, and foster collaboration among participants.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $25,000 )
2026	2026	GORDON RESEARCH CONFERENCES	5586 POST RD UNIT 2	EAST GREENWICH	RI	02818	KENT	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	1	5/12/2026	NEW	$25,000
														Subtotal = $25,000

Grand Total All Awards = $25,000

Top

All Categories

About

Search

Reports

Data Submission

Award Information

2026 Myelin Gordon Research Conference and Seminar

Award Number: R13NS149650

ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 05/11/2026

PERIOD OF PERFORMANCE END DATE: 04/30/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer